E-LIB Suche - Ergebnisse für: Hajizadeh, Nima - Sprache DE

Sortierung: Relevanz

Sortierung: Jahr

1

Tumor necrosis factor inhibitors and janus kinase inhibitor..:

Hajizadeh, Nima ; Heidari, Amirhossein ; Sadeghi, Sara..
PLOS ONE. 19 (2024) 2 - p. e0293433 , 2024

Link: https://doi.org/10.1371/..

2

New variants of COVID‐19 (XBB.1.5 and XBB.1.16, the "Arctur..:

Pourriyahi, Homa ; Hajizadeh, Nima ; Khosravi, Mina...
Immunity, Inflammation and Disease. 12 (2024) 6 - p. , 2024

Link: https://doi.org/10.1002/..

3

JAK Inhibitors in Cutaneous T-Cell Lymphoma: Friend or Foe?..:

Vahabi, Seyed Mohammad ; Bahramian, Saeed ; Esmaeili, Farzad...
Cancers. 16 (2024) 5 - p. 861 , 2024

Link: https://doi.org/10.3390/..

4

Autologous adipose tissue injection in the treatment of alo..:

Sadeghi, Sara ; Ghane, Yekta ; Hajizadeh, Nima.
Journal of Cosmetic Dermatology. , 2023

Link: https://doi.org/10.1111/..

5

PRISMA 2020 flow diagram for new systematic reviews which i..:

Nima Hajizadeh ; Amirhossein Heidari ; Sara Sadeghi.
doi:10.1371/journal.pone.0293433.g001. , 2024

Link: https://doi.org/10.1371/..

6

Characteristics of eligible studies utilizing tumor necrosi..:

Nima Hajizadeh ; Amirhossein Heidari ; Sara Sadeghi.
doi:10.1371/journal.pone.0293433.t002. , 2024

Link: https://doi.org/10.1371/..

7

The list of search strategies and final results on each dat..:

Nima Hajizadeh ; Amirhossein Heidari ; Sara Sadeghi.
doi:10.1371/journal.pone.0293433.s003. , 2024

Link: https://doi.org/10.1371/..

8

The list of search strategies and final results on each dat..:

Nima Hajizadeh ; Amirhossein Heidari ; Sara Sadeghi.
doi:10.1371/journal.pone.0293433.s003. , 2024

Link: https://doi.org/10.1371/..

9

The quality assessment included case reports and case serie..:

Nima Hajizadeh ; Amirhossein Heidari ; Sara Sadeghi.
doi:10.1371/journal.pone.0293433.s006. , 2024

Link: https://doi.org/10.1371/..

10

PRISMA 2020 checklist for reporting systematic reviews:

Nima Hajizadeh ; Amirhossein Heidari ; Sara Sadeghi.
doi:10.1371/journal.pone.0293433.s001. , 2024

Link: https://doi.org/10.1371/..

11

Characteristics of eligible studies with tumor necrosis fac..:

Nima Hajizadeh ; Amirhossein Heidari ; Sara Sadeghi.
doi:10.1371/journal.pone.0293433.t003. , 2024

Link: https://doi.org/10.1371/..

12

Characteristics of eligible studies utilizing tumor necrosi..:

Nima Hajizadeh ; Amirhossein Heidari ; Sara Sadeghi.
doi:10.1371/journal.pone.0293433.t002. , 2024

Link: https://doi.org/10.1371/..

13

The quality assessment included observational cohort and cr..:

Nima Hajizadeh ; Amirhossein Heidari ; Sara Sadeghi.
doi:10.1371/journal.pone.0293433.s004. , 2024

Link: https://doi.org/10.1371/..

14

PRISMA 2020 checklist for reporting systematic reviews:

Nima Hajizadeh ; Amirhossein Heidari ; Sara Sadeghi.
doi:10.1371/journal.pone.0293433.s001. , 2024

Link: https://doi.org/10.1371/..

15

The quality assessment included before-after studies with n..:

Nima Hajizadeh ; Amirhossein Heidari ; Sara Sadeghi.
doi:10.1371/journal.pone.0293433.s005. , 2024

Link: https://doi.org/10.1371/..

1-15